Beleaguered Spanish Drug Firm Grifols Stock Jumps On Monday - Here's Why
Beleaguered Spanish Drug Firm Grifols Stock Jumps On Monday - Here's Why
In a regulatory filing, Grifols SA (NASDAQ:GRFS) said that Brookfield Capital has confirmed that it has engaged in preliminary discussions with Grifols's key shareholders regarding a potential joint offer to delist the company's shares from the Spanish stock exchanges and NASDAQ.
基立福SA(NASDAQ:GRFS)在一份监管文件中表示，Brookfield Capital已确认已与Grifols的主要股东进行初步讨论，以就从西班牙证券交易所和纳斯达克退市的公司股份进行可能的联合报价。
Brookfield and the shareholders have signed an exclusivity agreement to explore this possibility further and requested access to certain company information to conduct due diligence.
Brookfield和股东已签署排他性协议，以进一步探讨这一可能性，并请求获得某些公司信息以进行尽职调查。
Also Read: Spanish Healthcare Firm Grifols' Reputational Damage and Debt Woes: European Central Bank Probes Lenders.
阅读更多：西班牙医疗保健公司Grifols的声誉损害和债务问题：欧洲中央银行调查贷方。
According to the information provided to the Board of Directors, Brookfield, and the Grifols family shareholders have agreed to evaluate a possible joint takeover bid to acquire Grifols.
根据向董事会提供的信息，Brookfield和Grifols家族股东已同意评估一项可能的联合收购要约以收购Grifols。
The Board of Directors held an extraordinary meeting to allow access to certain company information to carry out a due diligence process regarding the intent of the transaction, in case The board goes through, would be delisting the company.
董事会召开了一次特别会议，允许访问 certain company information 以进行尽职调查程序，此事项的意图是退市公司。
Reuters noted that the founding family members own a 30% stake in Grifols.
路透社指出，Grifols创始家族成员持有该公司30%的股份。
In a regulatory filing, the Comisión Nacional del Mercado de Valores made the following decision: "Effective from 12:00 PM today, the precautionary suspension of Grifols has been lifted, applying to shares and related securities on the Stock Exchanges and Sistema de Interconexión Bursátil, Derivative contracts on these shares on MEFF Sociedad Rectora del Mercado de Productos Derivados, S.A.U., and Fixed Income Instruments issued on the CAPI OTF.
在一份监管文件中，Comisión Nacional del Mercado de Valores做出了以下决定："从今天下午12:00起，Grifols的预防性暂停已经解除，适用于证券交易所和Sistema de Interconexión Bursátil、MEFF Sociedad Rectora del Mercado de Productos Derivados、CAPI OTF发行的固收工具。"
Earlier, CNMV agreed to suspend the trading of Grifols shares.
CNMV早些时候同意暂停Grifols股票交易。
The suspension was lifted because sufficient information about the circumstances leading to the suspension has been made public to market operators and the CNMV."
之所以解除暂停，是因为有关暂停的情况已经向市场运营商和CNMV公开披露。"
Citing business newspaper Cinco Dias, Reuters noted that the founding family aims to gain access to the company's books to make a final offer in the coming weeks.
援引商业报纸Cinco Dias，路透社指出，创始家族旨在获取公司账目，以在未来几周内提出最终报价。
Reuters highlighted that the deal could be worth around 5.5 billion euros ($5.96 billion).
路透社强调，交易价值可能约为55亿欧元（596亿美元）。
In March, Gotham City Research released a new report on Grifols questioning the company's "transparency, integrity and ethical conduct."
今年3月，Gotham City Research发布了一份有关Grifols的新报告，质疑该公司的"透明度、诚信和道德行为"。
Recently, Grifols appointed Rahul Srinivasan as the new Chief Financial Officer, effective September 16.
最近，Grifols任命Rahul Srinivasan为新的首席财务官，任期自9月16日起生效。
Price Action: GRFS shares are up 20.90% at $8.51 at the last check on Monday.
股票价格： GRFS股票在周一最后交易时上涨20.90美元至8.51美元。
- Grifols Gets Downgraded: Fitch, S&P Flag Cash Flow Concerns At Pharma Company.
- 格里福斯（Grifols）股票下调：Fitch，S&P标注药品公司现金流担忧。
Photo via Wikimedia Commons
照片通过Wikimedia Commons